Holen Sie sich die Stockscreener-App
0.292
7.28%
-0.0238
Renovaro Inc Aktie (RENB) Neueste Nachrichten
The Manufacturers Life Insurance Company Makes New $38,000 Investment in Renovaro Inc. (NASDAQ:RENB) - Defense World
Voya Investment Management LLC Acquires Shares of 35,312 Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro launches AI platform to advance neurology drug discovery By Investing.com - Investing.com Nigeria
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform - GlobeNewswire
Renovaro Launches Augusta, an AI-Powered Precision Neurology Pla - GuruFocus
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Barclays PLC - Defense World
Renovaro (REN) Unveils Augusta: A Breakthrough in Precision Neurology | RENB Stock News - GuruFocus
Renovaro BioSciences launches Augusta AI-powered precision neurology platform - TipRanks
Renovaro (REN) Unveils Augusta: A Breakthrough in Precision Neur - GuruFocus
Renovaro launches AI platform to advance neurology drug discovery - Investing.com
Renovaro BioSciences, Amsterdam UMC enter collaboration agreement - TipRanks
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Wells Fargo & Company MN - Defense World
Renovaro partners with Amsterdam UMC on cancer diagnostics - Investing.com
Renovaro and Amsterdam University Medical Center Announce Exclus - GuruFocus
Renovaro partners with Amsterdam UMC on cancer diagnostics By Investing.com - Investing.com India
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics - The Manila Times
Renovaro Inc. and Amsterdam UMC Enter Exclusive Collaboration to Develop Blood Platelet RNA Diagnostics - Nasdaq
Renovaro and Amsterdam University Medical Center Announce - GlobeNewswire
Biotech Tells Chancery Drug Co. Abused Merger Prospects - Law360
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by JPMorgan Chase & Co. - Defense World
Nothing is Better Than Renovaro Inc (RENB) stock at the moment - Sete News
How to interpret Renovaro Inc (RENB)’s stock chart patterns - uspostnews.com
Renovaro Inc’s latest rating changes from various analysts - knoxdaily.com
Renovaro Inc (RENB) Stock: Uncovering 52-Week Market Trends - investchronicle.com
RENB stock touches 52-week low at $0.32 amid market challenges - Investing.com India
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Geode Capital Management LLC - Defense World
Market Watch: Renovaro Inc (RENB)’s Noteworthy Gain, Closing at 0.37 - DWinneX
Investor’s Delight: Renovaro Inc (RENB) Closes Weak at 0.39, Down -16.49 - DWinneX
AI medicine company Renovaro to use Nebul's AI cloud infrastructure - Data Center Dynamics
Renovaro Inc [RENB] stock for 1,448 USD was sold by William Anderson Wittekind - knoxdaily.com
RENB’s 52-Week Rollercoaster: From $0.32 to $2.34 – What’s Next for Investors? - investchronicle.com
Renovaro BioSciences expands collaboration with Nebul - MSN
Insider’s View: Deciphering Renovaro Inc (RENB)’s Financial Health Through Ratios - DWinneX
Renovaro Inc (RENB)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Renovaro Expands Partnership With Nebul To Accelerate AI-Driven Cancer Diagnostics - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs | RENB Stock News - GuruFocus
Renovaro (ticker) and Nebul Enhance Partnership to Boost Diagnostic Innovations | RENB Stock News - GuruFocus
Renovaro Inc. Expands Collaboration with Nebul to Enhance Early Cancer Detection Through Advanced AI Technology - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Renovaro's New AI Partnership Targets Breakthrough in Early-Stage Lung Cancer Detection Technology - Stock Titan
Renovaro Inc (NASDAQ: RENB) Has Great Upside Potential - Stocksregister
Renovaro faces Nasdaq delisting over share price issue By Investing.com - Investing.com Canada
Renovaro faces Nasdaq delisting over share price issue - Investing.com
Renovaro Inc. (NASDAQ:RENB) Shares Purchased by Corebridge Financial Inc. - Defense World
Renovaro closes merger transaction with BioSymetrics - Pharmaceutical Business review -
Renovaro merges with BioSymetrics to boost AI drug discovery - Investing.com
Renovaro merges with BioSymetrics to boost AI drug discovery By Investing.com - Investing.com South Africa
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven B - GuruFocus
Walmart stands by its annual financial outlook but pulls back its 1Q view amid tariff uncertainty - The Globe and Mail
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewswire
Major AI Breakthrough: Renovaro-BioSymetrics Merger Creates Powerhouse in Precision Medicine - Stock Titan
0.78%
1.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):